Berberine Hyperglycemic Clamp

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
Berberine (BBR) is a traditional Chinese medicine used to treat diabetes mellitus for thousands of years in China. The glucose‐lowering effect of BBR has been confirmed in numerous studies. Nevertheless, the detailed mechanisms of action through which BBR exerts its effects are not yet fully elucidated. In previous data, Jin‐Kui Yang found that BBR could promote insulin secretion in mice and isolated islets. In this current study, investigators plan to examine the insulinotropic effect of BBR in human through hyperglycemic clamp method.
Epistemonikos ID: 2050a85a3a9523239991b3b1a175ac26d66e641a
First added on: May 22, 2024